Table 1.

Survival percentages at 30 and 300 days after TBI for the different treatments

Survival, dControl
n = 120
Treatment
TPO
n = 24
4Fsingle
n = 24
4F
n = 48
5F
n = 48
4F 10
n = 24
3F
n = 24
SDF-1
n = 24
30 8.3 58.3 62.50 81.25 87.5 45.8 50.0 29.2 
300 3.3 29.2 41.7 50.0 43.8 8.3 20.8 12.5 
Survival, dControl
n = 120
Treatment
TPO
n = 24
4Fsingle
n = 24
4F
n = 48
5F
n = 48
4F 10
n = 24
3F
n = 24
SDF-1
n = 24
30 8.3 58.3 62.50 81.25 87.5 45.8 50.0 29.2 
300 3.3 29.2 41.7 50.0 43.8 8.3 20.8 12.5 

TPO or SDF-1 indicates each cytokine alone; 3F, SCF + FLT-3 ligand + TPO; 4F, 3F + IL-3; 5F, 4F + SDF-1. TPO, SDF-1, 3F, 4F, and 5F were given 2 hours and 24 hours after TBI. Each cytokine was administered at 50 μg/kg. 4Fsingle is 4F given only at 2 hours after TBI. Each cytokine was given at 50 μg/kg. 4F10 is 4F given at 2 hours and 24 hours after TBI. Each cytokine was given at 10 μg/kg. Control, irradiated controls treated with cytokine diluent. The number (n) of mice for each group is indicated. See Table 2 for statistical significance.

Close Modal

or Create an Account

Close Modal
Close Modal